Patents by Inventor Ian Richard Buxton

Ian Richard Buxton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8637512
    Abstract: A sustained release formulation of lamotrigine or a pharmaceutically acceptable derivative thereof and methods of treatment and uses thereof.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: January 28, 2014
    Assignee: Glaxo Group Limited
    Inventors: Ian Richard Buxton, Wlodzimierz Karolak, Mehran Maleki, Vijay Mohan Iyer
  • Patent number: 7541350
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: June 2, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
  • Patent number: 6858596
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: February 22, 2005
    Assignee: SmithKline Beecham Corporation
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
  • Publication number: 20040192690
    Abstract: A sustained release formulation of lamotrigine or a pharmaceutically acceptable derivative thereof and methods of treatment and uses thereof.
    Type: Application
    Filed: December 4, 2003
    Publication date: September 30, 2004
    Inventors: Ian Richard Buxton, Robin Currie, Myrna A. Dela-Cruz, Gary Wayne Goodson, Wlodzimierz Karolak, Mehran Maleki, Vijay Mohan Iyer, Muppirala Gopal, Alan Frank Parr, Jagdey Singh Sidhu, Robert Allen Stagner, Akunuri Venkata Vijay-Kumar
  • Publication number: 20020165211
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) 1
    Type: Application
    Filed: February 4, 2002
    Publication date: November 7, 2002
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
  • Patent number: 5709851
    Abstract: A stable pharmaceutical composition with reduced irritancy is provided, the composition comprising an aqueous solution of elemental iodine and at least one organic substance which reacts with iodine, whereby iodine loss is controlled by providing a source of iodate ions in an amount sufficient to provide from 0.01% to 0.04% by weight iodate ions, preferably from 0.02% to 0.03% by weight iodate ions.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: January 20, 1998
    Assignee: Euro-Celtique, S.A.
    Inventors: Ian Richard Buxton, Stewart Thomas Leslie, Sandra Therese Antoinette Malkowska, Allan John Miller, Ronald Brown Miller, Derek Allan Prater
  • Patent number: 5670172
    Abstract: A controlled release composition including spheroid cores of diltiazem or a pharmaceutically acceptable salt thereof and optionally a spheronizing agent, the cores being coated with a controlled release layer, and a method of manufacturing the same, is disclosed. The spheronizing agent when present is preferably microcrystalline cellulose. Ethylcellulose is a preferred release coating. The controlled release coating preferably contains a plasticizer, a surfactant and a tack-modifier.
    Type: Grant
    Filed: April 21, 1995
    Date of Patent: September 23, 1997
    Assignee: Euro-Celtique, S.A.
    Inventors: Ian Richard Buxton, Helen Critchley, Stewart Thomas Leslie, Derek Allan Prater, Ronald Brown Miller, Sandra Therese Antoinette Malkowska